Arkolith/Insider Trading/SNTI/Form 4

Lu Timothy K

CEO, DirectorSenti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Feb 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18K
Net Open-Market Flow
-$18K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2025Sell(S)545$4.36$2K82K
Feb 4, 2025Sell(S)4K$4.07$16K83K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Senti Biosciences, Inc.

Build

Ask your agent about SNTI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001854270-25-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Senti Biosciences, Inc.
over the last 90 days and cite the filings.